Mutation detail:
| Mutation site | 1631T>C |
| Virus | Varicella-Zoster virus |
Mutation level  |
Nucleotide level |
| Gene/protein/region type | ORF2 |
| Gene ID | 1487680 |
| Country | - |
| Mutation type |
- |
| Genotype/subtype/clade | - |
| Sample |
cell line |
| Variants | - |
| Viral reference sequence | NC_001348.1 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Myristylated Tegument Protein CIRC |
| Uniprot protein ID | A0A2R4QFN8 |
| Protein length | 221 amino acids |
| Protein description | VZV ORF2 encodes a 26-kDa protein containing 221 amino acids. VZV ORF2 encodes a phosphoprotein located in the membrane of infected cells and has been shown to be dispensable for viral replication in vitro and for establishment of latency in the cotton rat model. |
Literature information:
| Pubmed ID | 29242077 |
| Clinical information | No |
| Disease | - |
| Published year | 2017 |
| Journal | Virus Passaged in Cell Culture |
| Title | Vaccine-Type Mutations Identified in Varicella Zoster Virus Passaged in Cell Culture |
| Author | Seok Cheon Kim1 , Youn Hee Won1 , Ji Seon Park1 , Jeong Seon Jeon1 , Jin Hyun Ahn |
| Evidence | Table3 |